Dr. Chad Costley became the President and Chief Executive Officer of BlueWillow Biologics in 2020 after serving on the Board of Directors for several years. Dr. Costley has 20 years of clinical practice experience and has advised and served on the Boards of Directors of several technology companies. As the managing director of Waubascon Capital and Line Moon Ventures, he’s led investment in and supported BlueWillow’s advancement for many years. He earned his MD at the University of Michigan where he also completed medical residency training. He holds an MBA with distinction from Emory University as a Woodruff Scholar.